{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:39:17Z","timestamp":1776922757545,"version":"3.51.2"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["444403\/2024-8"],"award-info":[{"award-number":["444403\/2024-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["304851\/2022-1"],"award-info":[{"award-number":["304851\/2022-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["309088\/2021-6"],"award-info":[{"award-number":["309088\/2021-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["309111\/2022-6"],"award-info":[{"award-number":["309111\/2022-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["305181\/2023-8"],"award-info":[{"award-number":["305181\/2023-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.pbb.2025.174053","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T18:30:29Z","timestamp":1749925829000},"page":"174053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cannabigerol does not affect contextual fear memory in mice but modulates nociception in a sex-dependent manner"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4235-1186","authenticated-orcid":false,"given":"Julia P.","family":"Andreotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9651-1988","authenticated-orcid":false,"given":"Lia P.","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-0468","authenticated-orcid":false,"given":"Rayssa C.","family":"Bri\u00e2nis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9628-7290","authenticated-orcid":false,"given":"Walace C.P.","family":"Barra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3891-5225","authenticated-orcid":false,"given":"Igor D.G.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1736-5503","authenticated-orcid":false,"given":"Cristina A.J.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2876-1146","authenticated-orcid":false,"given":"Leandro J.","family":"Bertoglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9520-6746","authenticated-orcid":false,"given":"Jos\u00e9 A.","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7635-8656","authenticated-orcid":false,"given":"Daniele C.","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0824-7302","authenticated-orcid":false,"given":"Fabr\u00edcio A.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2025.174053_bb0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbrc.2023.04.022","article-title":"Peripherally injected canabidiol reduces neuropathic pain in mice: role of the 5-HT1A and TRPV1 receptors","volume":"660","author":"Aguiar","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pbb.2025.174053_bb0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2014.09.004","article-title":"The antipsychotic aripiprazole selectively prevents the stimulant and rewarding effects of morphine in mice","volume":"742","author":"Almeida-Santos","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2025.174053_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/26331055231220340","article-title":"A comprehensive review on the regulatory action of TRP channels: a potential therapeutic target for nociceptive pain","volume":"18","author":"Anand","year":"2023","journal-title":"Neurosci. Insights"},{"key":"10.1016\/j.pbb.2025.174053_bb0020","doi-asserted-by":"crossref","unstructured":"N. Assareh, A. Gururajan, C. Zhou, J. L. Luo, R. C. Kevin, J. C. Arnold, \u201cCannabidiol disrupts conditioned fear expression and cannabidiolic acid reduces trauma-induced anxiety-related behaviour in mice\u201d, Behav. Pharmacol., vol. 31, no 6, p. 591\u2013596, set. 2020, doi:https:\/\/doi.org\/10.1097\/FBP.0000000000000565.","DOI":"10.1097\/FBP.0000000000000565"},{"key":"10.1016\/j.pbb.2025.174053_bb0025","doi-asserted-by":"crossref","unstructured":"S. Ben-Shabat, E. Fride, T. Sheskin, T. Tamiri, M.H. Rhee, Z. Vogel, T. Bisogno, L. De Petrocellis, V. Di Marzo, R. Mechoulam, \"An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity\", Eur. J. Pharmacol., vol. 353, no 1, p.23\u201331, 1998, doi:https:\/\/doi.org\/10.1016\/s0014-2999(98)00392-6.","DOI":"10.1016\/S0014-2999(98)00392-6"},{"key":"10.1016\/j.pbb.2025.174053_bb0030","first-page":"1","article-title":"Interplay between endocannabinoid and endovanilloid mechanisms in fear conditioning","author":"Bri\u00e2nis","year":"2023","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.pbb.2025.174053_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/3336516","article-title":"Pharmacological aspects and biological effects of Cannabigerol and its synthetic derivatives","volume":"nov. 2022","author":"Calapai","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.pbb.2025.174053_bb0040","doi-asserted-by":"crossref","unstructured":"M. Cascio, L. Gauson, L. Stevenson, R. Ross, R. Pertwee, \u201cEvidence that the plant cannabinoid cannabigerol is a highly potent \u03b12-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist: novel pharmacological actions of cannabigerol\u201d, Br. J. Pharmacol., vol. 159, no 1, p. 129\u2013141, jan. 2010, doi:https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00515.x.","DOI":"10.1111\/j.1476-5381.2009.00515.x"},{"key":"10.1016\/j.pbb.2025.174053_bb0045","doi-asserted-by":"crossref","unstructured":"C. Christensen, M. Rose, C. Cornett, M. Alles\u00f8. \"Decoding the postulated entourage effect of medicinal Cannabis: what it is and what it isn't\", Biomedicines, vol. 11, no 8, p. 2323, 2023, doi:https:\/\/doi.org\/10.3390\/biomedicines11082323.","DOI":"10.3390\/biomedicines11082323"},{"key":"10.1016\/j.pbb.2025.174053_bb0050","doi-asserted-by":"crossref","unstructured":"C. Cuttler, A. Stueber, Z. D. Cooper, E. Russo, \u201cAcute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial\u201d, Sci. Rep., vol. 14, no 1, p. 16163, jul. 2024, doi:https:\/\/doi.org\/10.1038\/s41598-024-66879-0.","DOI":"10.1038\/s41598-024-66879-0"},{"key":"10.1016\/j.pbb.2025.174053_bb0055","doi-asserted-by":"crossref","unstructured":"L. De Oliveira Alvares, B. Pasqualini Genro, F. Diehl, V. A. Molina, J. A. Quillfeldt, \u201cOpposite action of hippocampal CB1 receptors in memory reconsolidation and extinction\u201d, Neuroscience, vol. 154, no 4, p. 1648\u20131655, jul. 2008, doi:https:\/\/doi.org\/10.1016\/j.neuroscience.2008.05.005.","DOI":"10.1016\/j.neuroscience.2008.05.005"},{"key":"10.1016\/j.pbb.2025.174053_bb0060","doi-asserted-by":"crossref","unstructured":"L. De Petrocellis, T. Bisogno, M. Maccarrone, J. B. Davis, A. Finazzi-Agr\u00f2, V. Di Marzo, \u201cThe activity of anandamide at Vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism\u201d, J. Biol. Chem., vol. 276, no 16, p. 12856\u201312863, abr. 2001, doi:https:\/\/doi.org\/10.1074\/jbc.M008555200.","DOI":"10.1074\/jbc.M008555200"},{"key":"10.1016\/j.pbb.2025.174053_bb0065","doi-asserted-by":"crossref","unstructured":"L. De Petrocellis et al., \u201cEffects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes\u201d, Br. J. Pharmacol., vol. 163, no 7, p. 1479\u20131494, ago. 2011, doi:https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01166.x.","DOI":"10.1111\/j.1476-5381.2010.01166.x"},{"key":"10.1016\/j.pbb.2025.174053_bb0070","doi-asserted-by":"crossref","unstructured":"S. Deiana et al., \u201cPlasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), \u03949-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive\u2013compulsive behaviour\u201d, Psychopharmacology (Berl), vol. 219, no 3, p. 859\u2013873, fev. 2012, doi:https:\/\/doi.org\/10.1007\/s00213-011-2415-0.","DOI":"10.1007\/s00213-011-2415-0"},{"key":"10.1016\/j.pbb.2025.174053_bb0075","doi-asserted-by":"crossref","unstructured":"V. Di Marzo, F. Piscitelli, \u201cThe endocannabinoid system and its modulation by Phytocannabinoids\u201d, Neurotherapeutics, vol. 12, no 4, p. 692\u2013698, out. 2015, doi:https:\/\/doi.org\/10.1007\/s13311-015-0374-6.","DOI":"10.1007\/s13311-015-0374-6"},{"key":"10.1016\/j.pbb.2025.174053_bb0080","doi-asserted-by":"crossref","unstructured":"M. A. ElSohly, D. Slade, \u201cChemical constituents of marijuana: the complex mixture of natural cannabinoids\u201d, Life Sci., vol. 78, no 5, p. 539\u2013548, dez. 2005, doi:https:\/\/doi.org\/10.1016\/j.lfs.2005.09.011.","DOI":"10.1016\/j.lfs.2005.09.011"},{"key":"10.1016\/j.pbb.2025.174053_bb0085","doi-asserted-by":"crossref","unstructured":"C.J. Fowler, \"Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Non-psychoactive cannabinoids, 'entourage' compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effects\", Brain Res. Brain Res. Rev. vol. 41, no 1, p. 26\u201343, 2003, doi:https:\/\/doi.org\/10.1016\/s0165-0173(02)00218-7.","DOI":"10.1016\/S0165-0173(02)00218-7"},{"key":"10.1016\/j.pbb.2025.174053_bb0090","doi-asserted-by":"crossref","unstructured":"M. Frances Davies, J. Tsui, J. A. Flannery, X. Li, T. M. DeLorey, B. B. Hoffman, \u201cActivation of \u03b12 adrenergic receptors suppresses fear conditioning: expression of c-Fos and phosphorylated CREB in mouse amygdala\u201d, Neuropsychopharmacology, vol. 29, no 2, p. 229\u2013239, fev. 2004, doi:https:\/\/doi.org\/10.1038\/sj.npp.1300324.","DOI":"10.1038\/sj.npp.1300324"},{"key":"10.1016\/j.pbb.2025.174053_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109316","article-title":"Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors","volume":"223","author":"Franzen","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2025.174053_bb0100","doi-asserted-by":"crossref","unstructured":"K. Gamache, R. K. Pitman, K. Nader, \u201cPreclinical evaluation of reconsolidation blockade by clonidine as a potential novel treatment for posttraumatic stress disorder\u201d, Neuropsychopharmacology, vol. 37, no 13, p. 2789\u20132796, dez. 2012, doi:https:\/\/doi.org\/10.1038\/npp.2012.145.","DOI":"10.1038\/npp.2012.145"},{"key":"10.1016\/j.pbb.2025.174053_bb0105","doi-asserted-by":"crossref","unstructured":"Y. Gaoni, R. Mechoulam, \u201cIsolation, structure, and partial synthesis of an active constituent of hashish\u201d, J. Am. Chem. Soc., vol. 86, no 8, p. 1646\u20131647, abr. 1964a, doi:https:\/\/doi.org\/10.1021\/ja01062a046.","DOI":"10.1021\/ja01062a046"},{"key":"10.1016\/j.pbb.2025.174053_bb0110","article-title":"Structure and synthesis of cannabigerol, a new hashish constituent","volume":"82","author":"Gaoni","year":"1964","journal-title":"Proc. Chem. Soc."},{"key":"10.1016\/j.pbb.2025.174053_bb0115","doi-asserted-by":"crossref","unstructured":"P. H. Gobira et al., \u201cN-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: role of the cannabinoid CB1 receptor in the dorsal hippocampus\u201d, J. Psychopharmacol. (Oxf.), vol. 31, no 6, p. 750\u2013756, jun. 2017, doi:https:\/\/doi.org\/10.1177\/0269881117691567.","DOI":"10.1177\/0269881117691567"},{"key":"10.1016\/j.pbb.2025.174053_bb0120","doi-asserted-by":"crossref","unstructured":"Y. Grunfeld, H. Edery, \u201cPsychopharmacological activity of the active constituents of hashish and some related cannabinoids\u201d, Psychopharmacologia, vol. 14, no 3, p. 200\u2013210, 1969, doi:https:\/\/doi.org\/10.1007\/BF00404218.","DOI":"10.1007\/BF00404218"},{"key":"10.1016\/j.pbb.2025.174053_bb0125","doi-asserted-by":"crossref","unstructured":"W. Hall, N. Solowij, \u201cAdverse effects of cannabis\u201d, Lancet, vol. 352, no 9140, p. 1611\u20131616, nov. 1998, doi:https:\/\/doi.org\/10.1016\/S0140-6736(98)05021-1.","DOI":"10.1016\/S0140-6736(98)05021-1"},{"key":"10.1016\/j.pbb.2025.174053_bb0130","doi-asserted-by":"crossref","unstructured":"X. Han et al., \u201cComparison between cannabidiol and sertraline for the modulation of post-traumatic stress disorder-like behaviors and fear memory in mice\u201d, Psychopharmacology (Berl), vol. 239, no 5, p. 1605\u20131620, maio 2022, doi:https:\/\/doi.org\/10.1007\/s00213-022-06132-6.","DOI":"10.1007\/s00213-022-06132-6"},{"key":"10.1016\/j.pbb.2025.174053_bb0135","doi-asserted-by":"crossref","unstructured":"R. J. Harmon, P. D. Riggs, \u201cClonidine for posttraumatic stress disorder in preschool children\u201d, J. Am. Acad. Child Adolesc. Psychiatry, vol. 35, no 9, p. 1247\u20131249, set. 1996, doi:https:\/\/doi.org\/10.1097\/00004583-199609000-00022.","DOI":"10.1097\/00004583-199609000-00022"},{"key":"10.1016\/j.pbb.2025.174053_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109314","article-title":"TRPV1 modulation of contextual fear memory depends on stimulus intensity and endocannabinoid signalling in the dorsal hippocampus","volume":"224","author":"Iglesias","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2025.174053_bb0145","doi-asserted-by":"crossref","unstructured":"J. D. Kinzie, P. Leung, \u201cClonidine in Cambodian patients with posttraumatic stress disorder\u201d:, J. Nerv. Ment. Dis., vol. 177, no 9, p. 546\u2013550, set. 1989, doi:https:\/\/doi.org\/10.1097\/00005053-198909000-00005.","DOI":"10.1097\/00005053-198909000-00005"},{"key":"10.1016\/j.pbb.2025.174053_bb0150","doi-asserted-by":"crossref","unstructured":"P. P. Lakhlani et al., \u201cSubstitution of a mutant \u03b12a-adrenergic receptor via \u2018hit and run\u2019 gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo\u201d, Proc. Natl. Acad. Sci., vol. 94, no 18, p. 9950\u20139955, set. 1997, doi:https:\/\/doi.org\/10.1073\/pnas.94.18.9950.","DOI":"10.1073\/pnas.94.18.9950"},{"key":"10.1016\/j.pbb.2025.174053_bb0155","series-title":"em International Review of Neurobiology","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/bs.irn.2024.03.007","article-title":"Cannabidiol effects on fear processing and implications for PTSD: Evidence from rodent and human studies","volume":"vol. 177","author":"Lisboa","year":"2024"},{"key":"10.1016\/j.pbb.2025.174053_bb0160","doi-asserted-by":"crossref","unstructured":"M. Ma\u0107kowiak, A. Chocyk, D. Dudys, K. Wedzony, \u201cActivation of CB1 cannabinoid receptors impairs memory consolidation and hippocampal polysialylated neural cell adhesion molecule expression in contextual fear conditioning\u201d, Neuroscience, vol. 158, no 4, p. 1708\u20131716, fev. 2009, doi:https:\/\/doi.org\/10.1016\/j.neuroscience.2008.11.037.","DOI":"10.1016\/j.neuroscience.2008.11.037"},{"key":"10.1016\/j.pbb.2025.174053_bb0165","doi-asserted-by":"crossref","unstructured":"L. B. MacMillan, L. Hein, M. S. Smith, M. T. Piascik, L. E. Limbird, \u201cCentral hypotensive effects of the \u03b12a-adrenergic receptor subtype\u201d, Science, vol. 273, no 5276, p. 801\u2013803, ago. 1996, doi:https:\/\/doi.org\/10.1126\/science.273.5276.801.","DOI":"10.1126\/science.273.5276.801"},{"key":"10.1016\/j.pbb.2025.174053_bb0170","doi-asserted-by":"crossref","unstructured":"V. Marzo, L. Petrocellis, \u201cEndocannabinoids as regulators of transient receptor potential (TRP)channels: a further opportunity to develop new endocannabinoid-based therapeutic drugs\u201d, Curr. Med. Chem., vol. 17, no 14, p. 1430\u20131449, maio 2010, doi:https:\/\/doi.org\/10.2174\/092986710790980078.","DOI":"10.2174\/092986710790980078"},{"key":"10.1016\/j.pbb.2025.174053_bb0175","doi-asserted-by":"crossref","unstructured":"R. Mechoulam, A. Shani, H. Edery, Y. Grunfeld, \u201cChemical basis of hashish activity\u201d, Science, vol. 169, no 3945, p. 611\u2013612, ago. 1970, doi:https:\/\/doi.org\/10.1126\/science.169.3945.611.","DOI":"10.1126\/science.169.3945.611"},{"key":"10.1016\/j.pbb.2025.174053_bb0180","doi-asserted-by":"crossref","unstructured":"R. Mechoulam, E. Fride, V. Di Marzo, \"Endocannabinoids\", Eur. J. Pharmacol., vol 359, no 1, p. 1\u201318, 1998, doi:https:\/\/doi.org\/10.1016\/s0014-2999(98)00649-9.","DOI":"10.1016\/S0014-2999(98)00649-9"},{"key":"10.1016\/j.pbb.2025.174053_bb0185","doi-asserted-by":"crossref","unstructured":"R. Mechoulam, L. O. Hanu\u0161, R. Pertwee, A. C. Howlett, \u201cEarly phytocannabinoid chemistry to endocannabinoids and beyond\u201d, Nat. Rev. Neurosci., vol. 15, no 11, p. 757\u2013764, nov. 2014, doi:https:\/\/doi.org\/10.1038\/nrn3811.","DOI":"10.1038\/nrn3811"},{"key":"10.1016\/j.pbb.2025.174053_bb0190","doi-asserted-by":"crossref","unstructured":"Eva Mikics et al., \u201cThe effects of cannabinoids on contextual conditioned fear in CB1 knockout and CD1 mice\u201d:, Behav. Pharmacol., vol. 17, no 3, p. 223\u2013230, maio 2006, doi:https:\/\/doi.org\/10.1097\/00008877-200605000-00003.","DOI":"10.1097\/00008877-200605000-00003"},{"key":"10.1016\/j.pbb.2025.174053_bb0195","doi-asserted-by":"crossref","unstructured":"R. Nachnani, W. M. Raup-Konsavage, K. E. Vrana, \u201cThe pharmacological case for Cannabigerol\u201d, J. Pharmacol. Exp. Ther., vol. 376, no 2, p. 204\u2013212, fev. 2021, doi:https:\/\/doi.org\/10.1124\/jpet.120.000340.","DOI":"10.1124\/jpet.120.000340"},{"key":"10.1016\/j.pbb.2025.174053_bb0200","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbr.2015.12.017","article-title":"Modulation of cannabinoid signaling by amygdala \u03b12-adrenergic system in fear conditioning","volume":"300","author":"Nasehi","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2025.174053_bb0205","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fphar.2018.00632","article-title":"Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1\u2013CB2 Heteroreceptor complexes","volume":"9","author":"Navarro","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pbb.2025.174053_bb0210","doi-asserted-by":"crossref","unstructured":"F. A. Pamplona, R. N. Takahashi, \u201cWIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors\u201d, Neurosci. Lett., vol. 397, no 1\u20132, p. 88\u201392, abr. 2006, doi:https:\/\/doi.org\/10.1016\/j.neulet.2005.12.026.","DOI":"10.1016\/j.neulet.2005.12.026"},{"key":"10.1016\/j.pbb.2025.174053_bb0215","doi-asserted-by":"crossref","unstructured":"R. G. Pertwee, \u201cThe diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin\u201d, Br. J. Pharmacol., vol. 153, no 2, p. 199\u2013215, jan. 2008, doi:https:\/\/doi.org\/10.1038\/sj.bjp.0707442.","DOI":"10.1038\/sj.bjp.0707442"},{"key":"10.1016\/j.pbb.2025.174053_bb0220","doi-asserted-by":"crossref","unstructured":"W. H. Powell, L. E. Annett, R. Depoortere, A. Newman-Tancredi, M. M. Iravani, \u201cThe selective 5-HT1A receptor agonist NLX-112 displays anxiolytic-like activity in mice\u201d, Naunyn Schmiedebergs Arch. Pharmacol., vol. 395, no 2, p. 149\u2013157, fev. 2022, doi:https:\/\/doi.org\/10.1007\/s00210-021-02183-2.","DOI":"10.1007\/s00210-021-02183-2"},{"key":"10.1016\/j.pbb.2025.174053_bb0225","doi-asserted-by":"crossref","unstructured":"A. M. Raymundi, T. R. Da Silva, A. R. Zampronio, F. S. Guimar\u00e3es, L. J. Bertoglio, C. A. J. Stern, \u201cA time-dependent contribution of hippocampal CB1, CB2 and PPAR\u03b3 receptors to cannabidiol-induced disruption of fear memory consolidation\u201d, Br. J. Pharmacol., vol. 177, no 4, p. 945\u2013957, fev. 2020, doi:https:\/\/doi.org\/10.1111\/bph.14895.","DOI":"10.1111\/bph.14895"},{"key":"10.1016\/j.pbb.2025.174053_bb0230","doi-asserted-by":"crossref","unstructured":"L. B. M. Resstel, S. R. L. Joca, F. A. Moreira, F. M. A. Corr\u00eaa, F. S. Guimar\u00e3es, \u201cEffects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats\u201d, Behav. Brain Res., vol. 172, no 2, p. 294\u2013298, set. 2006, doi:https:\/\/doi.org\/10.1016\/j.bbr.2006.05.016.","DOI":"10.1016\/j.bbr.2006.05.016"},{"key":"10.1016\/j.pbb.2025.174053_bb0235","doi-asserted-by":"crossref","unstructured":"E. M. Rock et al., \u201cInteraction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews\u201d, Psychopharmacology (Berl), vol. 215, no 3, p. 505\u2013512, jun. 2011, doi:https:\/\/doi.org\/10.1007\/s00213-010-2157-4.","DOI":"10.1007\/s00213-010-2157-4"},{"key":"10.1016\/j.pbb.2025.174053_bb0240","doi-asserted-by":"crossref","unstructured":"E. Russo, \"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects\", Br. J. Pharmacol., vol. 163, no 7, p. 1344\u201364, 2011, doi:https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01238.x.","DOI":"10.1111\/j.1476-5381.2011.01238.x"},{"key":"10.1016\/j.pbb.2025.174053_bb0245","doi-asserted-by":"crossref","unstructured":"E. B. Russo, C. Cuttler, Z. D. Cooper, A. Stueber, V. L. Whiteley, M. Sexton, \u201cSurvey of patients employing Cannabigerol-predominant Cannabis preparations: perceived medical effects, adverse events, and withdrawal symptoms\u201d, Cannabis Cannabinoid Res., vol. 7, no 5, p. 706\u2013716, out. 2022, doi:https:\/\/doi.org\/10.1089\/can.2021.0058.","DOI":"10.1089\/can.2021.0058"},{"key":"10.1016\/j.pbb.2025.174053_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108684","article-title":"Female but not male rats show biphasic effects of low doses of \u03949-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?","volume":"196","author":"Salviato","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2025.174053_bb0255","doi-asserted-by":"crossref","unstructured":"J. Schweimer, M. Fendt, H.-U. Schnitzler, \u201cEffects of clonidine injections into the bed nucleus of the stria terminalis on fear and anxiety behavior in rats\u201d, Eur. J. Pharmacol., vol. 507, no 1\u20133, p. 117\u2013124, jan. 2005, doi:https:\/\/doi.org\/10.1016\/j.ejphar.2004.11.044.","DOI":"10.1016\/j.ejphar.2004.11.044"},{"key":"10.1016\/j.pbb.2025.174053_bb0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroscience.2022.04.009","article-title":"Memory consolidation depends on endogenous hippocampal levels of anandamide: CB1 and M4, but possibly not TRPV1 receptors mediate AM404 effects","volume":"497","author":"Scienza-Martin","year":"2022","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2025.174053_bb0265","doi-asserted-by":"crossref","unstructured":"D. E. Sepulveda, D. P. Morris, W. M. Raup-Konsavage, D. Sun, K. E. Vrana, N. M. Graziane, \u201cCannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy-induced peripheral neuropathy\u201d, Eur. J. Pain, vol. 26, no 9, p. 1950\u20131966, out. 2022, doi:https:\/\/doi.org\/10.1002\/ejp.2016.","DOI":"10.1002\/ejp.2016"},{"key":"10.1016\/j.pbb.2025.174053_bb0270","doi-asserted-by":"crossref","unstructured":"J. L. Q. Simei, J. D. R. Souza, J. R. Lisboa, A. C. Campos, F. S. Guimar\u00e3es, A. Zuardi, J. A. S. Crippa, \"Does the \"entourage effect\" in cannabinoids exist? A narrative scoping review\", Cannabis Cannabinoid Res., vol. 9, no 5, p. 1202\u20131216, 2024, doi:https:\/\/doi.org\/10.1089\/can.2023.0052.","DOI":"10.1089\/can.2023.0052"},{"key":"10.1016\/j.pbb.2025.174053_bb0275","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neuropharm.2017.07.024","article-title":"Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors","volume":"125","author":"Stern","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2025.174053_bb0280","doi-asserted-by":"crossref","unstructured":"O. Stiedl, I. Misane, J. Spiess, S. O. \u00d6gren, \u201cInvolvement of the 5-HT 1A receptors in classical fear conditioning in C57BL\/6J mice\u201d, J. Neurosci., vol. 20, no 22, p. 8515\u20138527, nov. 2000, doi:https:\/\/doi.org\/10.1523\/JNEUROSCI.20-22-08515.2000.","DOI":"10.1523\/JNEUROSCI.20-22-08515.2000"},{"key":"10.1016\/j.pbb.2025.174053_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.871962","article-title":"Acute Cannabigerol administration lowers blood pressure in mice","volume":"13","author":"Vernail","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.pbb.2025.174053_bb0290","doi-asserted-by":"crossref","unstructured":"T. G. Viana, A. F. Almeida-Santos, D. C. Aguiar, F. A. Moreira, \"Effects of aripiprazole, an atypical antipsychotic, on the motor alterations induced by acute ethanol administration in mice\" Basic Clin. Pharmacol. Toxicol. vol. 112, no 5, p. 319\u201324. 2013, doi:https:\/\/doi.org\/10.1111\/bcpt.12036.","DOI":"10.1111\/bcpt.12036"},{"key":"10.1016\/j.pbb.2025.174053_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173883","article-title":"Orally administered Cannabigerol (CBG) in rats: cannabimimetic actions, anxiety-like behavior, and inflammation-induced pain","volume":"245","author":"Weerts","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2025.174053_bb0300","doi-asserted-by":"crossref","unstructured":"J. Youn et al., \u201cBidirectional modulation of classical fear conditioning in mice by 5-HT1A receptor ligands with contrasting intrinsic activities\u201d, Neuropharmacology, vol. 57, no 5\u20136, p. 567\u2013576, out. 2009, doi:https:\/\/doi.org\/10.1016\/j.neuropharm.2009.07.011.","DOI":"10.1016\/j.neuropharm.2009.07.011"},{"key":"10.1016\/j.pbb.2025.174053_bb0305","doi-asserted-by":"crossref","unstructured":"A. Zagzoog et al., \u201cIn vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa\u201d, Sci. Rep., vol. 10, no 1, p. 20405, nov. 2020, doi:https:\/\/doi.org\/10.1038\/s41598-020-77175-y.","DOI":"10.1038\/s41598-020-77175-y"},{"key":"10.1016\/j.pbb.2025.174053_bb0310","doi-asserted-by":"crossref","unstructured":"C. Zhou, N. Assareh, J. C. Arnold, \u201cThe Cannabis constituent Cannabigerol does not disrupt fear memory processes or stress-induced anxiety in mice\u201d, Cannabis Cannabinoid Res., vol. 7, no 3, p. 294\u2013303, jun. 2022, doi:https:\/\/doi.org\/10.1089\/can.2021.0027.","DOI":"10.1089\/can.2021.0027"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305725001005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305725001005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:46:04Z","timestamp":1776919564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305725001005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":62,"alternative-id":["S0091305725001005"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2025.174053","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabigerol does not affect contextual fear memory in mice but modulates nociception in a sex-dependent manner","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2025.174053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"174053"}}